.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Merck
AstraZeneca
Healthtrust
Accenture
Chubb
QuintilesIMS
Deloitte
UBS
McKesson
Farmers Insurance

Generated: July 25, 2017

DrugPatentWatch Database Preview

NEURONTIN Drug Profile

« Back to Dashboard

Which patents cover Neurontin, and what generic Neurontin alternatives are available?

Neurontin is a drug marketed by Parke Davis and Pfizer Pharms and is included in three NDAs. There are two patents protecting this drug.

The generic ingredient in NEURONTIN is gabapentin. There are twenty-six drug master file entries for this compound. One hundred and five suppliers are listed for this compound. Additional details are available on the gabapentin profile page.

Summary for Tradename: NEURONTIN

Patents:2
Applicants:2
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list93
Clinical Trials: see list40
Patent Applications: see list6,031
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NEURONTIN at DailyMed

Pharmacology for Tradename: NEURONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
NEURONTIN
gabapentin
SOLUTION;ORAL021129-001Mar 2, 2000AARXYesYes► Subscribe► SubscribeY► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
TABLET;ORAL020882-002Oct 9, 1998ABRXYesYes► Subscribe► SubscribeY► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-002Dec 30, 1993ABRXYesNo► Subscribe► SubscribeY► Subscribe
Parke Davis
NEURONTIN
gabapentin
SOLUTION;ORAL021129-001Mar 2, 2000AARXYesYes► Subscribe► SubscribeY► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-001Dec 30, 1993ABRXYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: NEURONTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-001Dec 30, 1993► Subscribe► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-003Dec 30, 1993► Subscribe► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
TABLET;ORAL020882-002Oct 9, 1998► Subscribe► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
CAPSULE;ORAL020235-002Dec 30, 1993► Subscribe► Subscribe
Pfizer Pharms
NEURONTIN
gabapentin
TABLET;ORAL020882-001Oct 9, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
AstraZeneca
Harvard Business School
Colorcon
Chubb
US Army
Merck
Citi
Teva
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot